Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,683	2,355	1,887	1,489	1,134	1,046
Revenue Growth (YoY)	19.61%	24.81%	26.76%	31.34%	8.38%	32.71%
Cost of Revenue	986.9	765.1	604.7	487	342.4	285.1
Gross Profit	1,696	1,590	1,282	1,002	791.1	760.8
Selling, General & Admin	1,156	1,007	887.6	752.7	583.3	433.3
Operating Expenses	1,156	1,007	887.6	752.7	583.3	433.3
Operating Income	540.3	583	394.8	249	207.8	327.5
Interest Expense	-	-	-	-	-25.8	-32.8
Interest & Investment Income	87	91	52.8	4.1	3.8	12.6
EBT Excluding Unusual Items	627.3	674	447.6	253.1	185.8	307.3
Gain (Loss) on Sale of Investments	-8.6	-37.1	28.4	30.8	20.9	-17.7
Other Unusual Items	-	-138.4	-	-70	-	-18.4
Pretax Income	628.6	486	332.1	213.9	101.4	106.7
Income Tax Expense	200.6	144.7	82.4	59.4	11.8	-300.6
Net Income	428	341.3	249.7	154.5	89.6	407.3
Net Income to Common	428	341.3	249.7	154.5	89.6	407.3
Net Income Growth	10.91%	36.68%	61.62%	72.43%	-78.00%	1000.81%
Shares Outstanding (Basic)	99	100	98	96	95	93
Shares Outstanding (Diluted)	102	104	101	99	98	98
Shares Change (YoY)	-1.30%	2.67%	2.12%	1.02%	0.10%	2.19%
EPS (Basic)	4.30	3.40	2.56	1.61	0.95	4.37
EPS (Diluted)	4.19	3.29	2.47	1.56	0.92	4.16
EPS Growth	12.44%	33.20%	58.33%	69.56%	-77.89%	966.67%
Free Cash Flow	593.1	557.2	361.6	322.9	233.1	217.6
Free Cash Flow Per Share	5.80	5.37	3.58	3.27	2.38	2.23
Gross Margin	63.21%	67.52%	67.96%	67.29%	69.79%	72.74%
Operating Margin	20.14%	24.75%	20.92%	16.73%	18.33%	31.31%
Profit Margin	15.95%	14.49%	13.23%	10.38%	7.90%	38.94%
Free Cash Flow Margin	22.11%	23.66%	19.16%	21.69%	20.57%	20.80%
EBITDA	570	610.1	416.1	264.6	218.7	336.1
EBITDA Margin	21.25%	25.90%	22.05%	17.77%	19.29%	32.14%
D&A For EBITDA	29.7	27.1	21.3	15.6	10.9	8.6
EBIT	540.3	583	394.8	249	207.8	327.5
EBIT Margin	20.14%	24.75%	20.92%	16.73%	18.33%	31.31%
Effective Tax Rate	31.91%	29.77%	24.81%	27.77%	11.64%	-
Revenue as Reported	2,683	2,355	1,887	1,489	1,134	1,046
Advertising Expenses	-	191	159.9	149.7	139.8	64.8

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q